Global Ventricular Assist Devices Market to Reach US$ 2.80 Billion by 2027, Fueled by Rising Prevalence of CVDs

December 04, 2020

According to the latest report by IMARC Group, titled “Ventricular Assist Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” the global ventricular assist devices market reached a value of US$ 1.56 Billion in 2021. Ventricular assist devices (VADs) are circulatory support equipment that ensures the proper flow of blood in one’s body. They function by pumping blood from the lower chambers of ventricles to the rest of the organs. They are equipped with an electronic controller, tubes and a power source that assist in cardiac circulation among patients with heart failure. As a result, they are considered to be a preferred therapeutic solution for patients suffering from end-stage heart failure as VADs help increase their life expectancy with an improved quality of life

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Global Ventricular Assist Devices Market Trends:

The global market is primarily driven by the increasing prevalence of cardiovascular diseases among the masses. In line with this, the changing lifestyle patterns of individuals and the busy schedules led by working professionals are providing an impetus to the market growth. Moreover, the rising geriatric population, which is more susceptible to developing medical ailments, is providing an impetus to the market growth. Furthermore, various technological advancements across the healthcare sector, along with the miniaturization of VADs, are significantly contributing to the market growth across the globe. Additionally, increasing funding and investments by public and private firms to upgrade the existing healthcare infrastructure are positively influencing the market growth. Other factors, including rising healthcare expenditure, continuous product innovations and extensive research and development (R&D) activities conducted by key players, are further projected to drive the market growth. On account of the aforementioned factors,?the market is anticipated to reach a value of US$ 2.80 Billion by 2027, growing at a CAGR of 10.09% during 2022-2027.

Market Summary:

On the basis of the product, the market has been segregated into left ventricular assist device (LVAD), right ventricular assist device (RVAD), biventricular assist device (BiVAD) and others.

  • Based on the flow type, the market has been bifurcated into pulsatile flow and non-pulsatile or continuous flow.
  • Based on the product type, the market has been segmented into implantable and non-implantable ventricular assist devices.
  • Based on the application, the market has been categorized into bridge-to-transplant (BTT) therapy, destination therapy and bridge to recovery, and bridge to candidacy.
  • On the basis of the end-user, the market has been classified into ambulatory surgery centers, hospitals and others.
  • Based on the region, the market has been divided into North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others), Latin America (Brazil, Mexico and others) and the Middle East and Africa.
  • The competitive landscape of the market has been studied in the report with the detailed profiles of the key players. Some of the key players include Abbott Laboratories, Abiomed Inc., Berlin Heart GmbH (Syscore GmbH), Bivacor Inc., Calon Cardio, Cardiacassist Inc. (LivaNova PLC), CHF Solutions Inc., Jarvik Heart Inc., MAQUET GmbH (Getinge), Medtronic Inc., Syncardia Systems LLC (Versa Capital Management LLC), TandemLife (LivaNova PLC) and Terumo Corporation.


About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

Tel no: +1-631-791-1145

Global Ventricular Assist Devices Market to Reach US$ 2.80 Billion by 2027, Fueled by Rising Prevalence of CVDs
Select Licence Type

Benefits of Customization

Personalize This Research

Triangulate with your Data

Get Data as per your Format and Definition

Gain a Deeper Dive into a Specific Application, Geography, Customer or Competitor

Any level of Personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-713-2163


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Bayer AH

It was indeed a great experience to work with IMARC on the assignment on Aqua market. The team had done a fantastic job in terms of what was expected, what was assured and what was the result… the report gave us many insights and market know how which allowed us to work on our strength and define exact strategies…

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More